Psychedelics: The Revolution Will Be Monetized & Trademarked
Cannabis Law Report
JANUARY 20, 2020
Bruce Linton Talks Psychedelics Investments, Microdosing And LSD: ‘The Therapeutic Potential Of Psychedelics Is Greater Than Cannabinoids’ Earlier this year, Canopy Growth CGC 2.31% co-founder and former CEO Bruce Linton invested in a neuropharmaceutical company, Mind Medicine Inc. . Firstly Mr Linton tells Benzinga.
Let's personalize your content